15 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
, or the Securities Exchange Act of 1934, as amended.
The primary purpose of the Audit Committee is to oversee our financial reporting processes
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; and established … experience to oversee the relationships with our contract manufacturers.
Competition
Neumora is a clinical-stage biopharmaceutical company founded
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
the 340B drug pricing program;
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical … ; expanded eligibility criteria for Medicaid programs; created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
for discounts under the 340B drug pricing program;
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct … eligibility criteria for Medicaid programs; created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct
S-1
EX-10.2
dccrmy6nj8dwa7kehr
25 Aug 23
IPO registration
5:03pm
S-1
iio j1w94vk54zj8agd
25 Aug 23
IPO registration
5:03pm
DRS/A
z6jt898lz1335j aj81m
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
8fet rhxp6dii
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
mepl0lxw
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
0v9xjhr 88x
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
27z1e9cfc96hb0
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
6n01 vpatfwb1zl7ge8p
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
t8onqt8
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
oiiefku9k
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next